| Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis V Arvaniti, G D'Amico, G Fede, P Manousou, E Tsochatzis, M Pleguezuelo, ... Gastroenterology 139 (4), 1246-1256. e5, 2010 | 1403 | 2010 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1169 | 2019 |
| Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study B Hanley, KN Naresh, C Roufosse, AG Nicholson, J Weir, GS Cooke, ... The Lancet Microbe 1 (6), e245-e253, 2020 | 592 | 2020 |
| Transjugular liver biopsy–indications, adequacy, quality of specimens, and complications–a systematic review G Kalambokis, P Manousou, S Vibhakorn, L Marelli, E Cholongitas, ... Journal of hepatology 47 (2), 284-294, 2007 | 436 | 2007 |
| Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials SA Harrison, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi, ... Journal of hepatology 73 (1), 26-39, 2020 | 389 | 2020 |
| Non-alcoholic fatty liver disease J Maurice, P Manousou Clinical medicine 18 (3), 245-250, 2018 | 382 | 2018 |
| Computer‐assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient V Calvaruso, AK Burroughs, R Standish, P Manousou, F Grillo, G Leandro, ... Hepatology 49 (4), 1236-1244, 2009 | 367 | 2009 |
| Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder JU Kim, A Majid, R Judge, P Crook, R Nathwani, N Selvapatt, ... The Lancet Gastroenterology & Hepatology 5 (10), 886-887, 2020 | 237 | 2020 |
| Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation E Cholongitas, V Shusang, GV Papatheodoridis, L Marelli, P Manousou, ... Liver transplantation 14 (2), 138-143, 2008 | 207 | 2008 |
| Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non‐alcoholic fatty liver disease patients P Manousou, G Kalambokis, F Grillo, J Watkins, E Xirouchakis, ... Liver International 31 (5), 730-739, 2011 | 174 | 2011 |
| Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis E Tsochatzis, S Bruno, G Isgro, A Hall, E Theocharidou, P Manousou, ... Journal of hepatology 60 (5), 948-954, 2014 | 170 | 2014 |
| High-throughput, machine learning–based quantification of steatosis, inflammation, ballooning, and fibrosis in biopsies from patients with nonalcoholic fatty liver disease R Forlano, BH Mullish, N Giannakeas, JB Maurice, N Angkathunyakul, ... Clinical Gastroenterology and Hepatology 18 (9), 2081-2090. e9, 2020 | 125 | 2020 |
| Pegylated‐interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta‐analysis of prospective controlled studies E Xirouchakis, C Triantos, P Manousou, A Sigalas, V Calvaruso, ... Journal of Viral Hepatitis 15 (10), 699-709, 2008 | 119 | 2008 |
| TACE versus TAE as therapy for hepatocellular carcinoma M Pleguezuelo, L Marelli, M Misseri, G Germani, V Calvaruso, ... Expert review of anticancer therapy 8 (10), 1623-1641, 2008 | 116 | 2008 |
| Prognostic models in cirrhotics admitted to intensive care units better predict outcome when assessed at 48 h after admission E Cholongitas, A Betrosian, M Senzolo, S Shaw, D Patch, P Manousou, ... Journal of gastroenterology and hepatology 23 (8pt1), 1223-1227, 2008 | 107 | 2008 |
| The effects of dietary supplementation with inulin and inulin‐propionate ester on hepatic steatosis in adults with non‐alcoholic fatty liver disease ES Chambers, CS Byrne, A Rugyendo, DJ Morrison, T Preston, C Tedford, ... Diabetes, Obesity and Metabolism 21 (2), 372-376, 2019 | 96 | 2019 |
| Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation P Manousou, AP Dhillon, G Isgro, V Calvaruso, TV Luong, E Tsochatzis, ... Liver Transplantation 17 (2), 178-188, 2011 | 96 | 2011 |
| Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis E Xirouchakis, L Marelli, E Cholongitas, P Manousou, V Calvaruso, ... Clinical Journal of the American Society of Nephrology 6 (1), 84-92, 2011 | 90 | 2011 |
| Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis DN Samonakis, E Cholongitas, U Thalheimer, G Kalambokis, A Quaglia, ... Liver Transplantation 13 (9), 1305-1311, 2007 | 85 | 2007 |
| Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: implication in intestinal fibrosis I Drygiannakis, V Valatas, O Sfakianaki, L Bourikas, P Manousou, ... Journal of Crohn's and Colitis 7 (4), 286-300, 2013 | 83 | 2013 |
